(Q43651437)

25 November 2017

Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease (English)

1 reference

25 November 2017

0 references

Blann AD

1

1 reference

25 November 2017

Gurney D

2

1 reference

25 November 2017

Hughes E

3

1 reference

25 November 2017

Buggins P

4

1 reference

25 November 2017

Silverman SH

5

1 reference

25 November 2017

Lip GY

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

American Journal of Cardiology

25 November 2017

1 reference

25 November 2017

88

1 reference

25 November 2017

A7-8, 89-92

1 reference

25 November 2017

1

1 reference

Hypothesis: is soluble P-selectin a new marker of platelet activation?

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

A reliable marker of endothelial cell dysfunction: does it exist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Effect of statins on C-reactive protein in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Decrease in P-selectin levels in patients with hypercholesterolaemia and peripheral arterial occlusive disease after lipid-lowering treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Lipid-lowering therapy corrects endothelial cell dysfunction in a short time but does not affect hypercoagulable state even after long-term use in hyperlipidemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Von Willebrand factor and soluble E-selectin in hyperlipidaemia: relationship to lipids and vascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Statins do more than just lower cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

Lipids and the endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2801%2901597-1

10.1016/S0002-9149(01)01597-1

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference